Concepedia

Xiaojuan Su

XS

Statistics

Publications

16

Citations

439

H-Index

12

Active since

2017

Affiliations

Sichuan University(Current)

West China Second University Hospital of Sichuan University

Shanxi University

State Key Laboratory of Oral Diseases

Xiaojuan Su is an author at Sichuan University specializing in life sciences, hypoxic-ischemic brain injury, and pharmacology.

ORCID

Publications per year

2017–2024

16

Publications

16

Melatonin improves hypoxic-ischemic brain damage through the Akt/Nrf2/Gpx4 signaling pathway

Zhixian Gou, Xiaojuan Su, Xing Hu et al. · Brain Research Bulletin · 2020 · 148 citations · Full text

, , +17

Daphnes Cortex and its licorice-processed products suppress inflammation via the TLR4/NF-κB/NLRP3 signaling pathway and regulation of the metabolic profile in the treatment of rheumatoid arthritis

Xianglong Meng, Xiaoyan Zhang, Xiaojuan Su et al. · Journal of Ethnopharmacology · 2021 · 46 citations · Full text

, , +17

Microglia and Their Promising Role in Ischemic Brain Injuries: An Update

Luting Yu, Xiaojuan Su, Shiping Li et al. · Frontiers in Cellular Neuroscience · 2020 · 36 citations · Full text

, , +17

GSK484, an inhibitor of peptidyl arginine deiminase 4, increases the radiosensitivity of colorectal cancer and inhibits neutrophil extracellular traps

Binbin Wang, Xiaojuan Su, Bo Zhang et al. · The Journal of Gene Medicine · 2023 · 31 citations

, , +16

Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?

Dongqiong Xiao, Xihong Li, Xiaojuan Su et al. · International Journal of Infectious Diseases · 2020 · 27 citations · Full text

, , +15

1–5 of 16